The COVID-19/Influenza A+B Antigen Combo Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2, influenza A and influenza B viral nucleocapsid protein antigens in nasal swab from individuals suspected of being infected with COVID-19 within the first 7 days of symptom onset or influenza within the first 4 days of symptom onset. This test is intended for self-use by persons aged 15 years or above and for an adult testing another person under 15 years of age. Individuals over 65 years of age should consider seeking assistance in performing the test.
The test is an aid for diagnosis of COVID-19/Influenza A+B and only provides a presumptive test result for the SARS-CoV-2, influenza A and influenza B virus. It is intended to be used in the home or similar environment by a lay person.
| Catalog No. | Specifications | Reaction Time | Sensitivity | Specificity | Storage Condition | Shelf Life | Certification |
|---|---|---|---|---|---|---|---|
| ISrlDu325-B001 | 1 test/box | 15 mins |
95.3% for COVID-19 94.4% for Influenza A |
99.8% for COVID-19 |
4-30℃ | 24 months |
TGA |
| ISrlDu325-B002 | 2 tests/box | ||||||
| ISrlDu325-B005 | 5 tests/box | ||||||
| ISrlDu325-B0020 | 20 tests/box |
This product cannot be sold in the United States.
